Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial (Q34397841)

1 August 2017

Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial (English)

1 reference

1 August 2017

0 references

1 reference

personalized medicine

1 reference

Benjamin French

1

1 reference

1 August 2017

Jungnam Joo

2

1 reference

1 August 2017

Nancy L Geller

3

1 reference

1 August 2017

Stephen E Kimmel

4

1 reference

1 August 2017

Yves Rosenberg

5

1 reference

1 August 2017

Jeffrey L Anderson

6

1 reference

1 August 2017

Brian F Gage

7

1 reference

1 August 2017

Julie A Johnson

8

1 reference

1 August 2017

Jonas H Ellenberg

9

1 reference

1 August 2017

COAG (Clarification of Optimal Anticoagulation through Genetics) Investigators

10

1 reference

1 August 2017

language of work or name

1 reference

17 November 2010

1 reference

1 August 2017

1 reference

1 August 2017

11

1 reference

1 August 2017

108

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

start time

17 November 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1745-6215-11-108

0 references

cites work

Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Integration of genetic, clinical, and INR data to refine warfarin dosing

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Estimation of the warfarin dose with clinical and pharmacogenetic data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

The use of genomics in clinical trial design

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Clinical trial designs for predictive marker validation in cancer treatment trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Trials within trials: confirmatory subgroup analyses in controlled clinical experiments

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

P-value interpretation and alpha allocation in clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

An examination of methods for sample size recalculation during an experiment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

A method to determine the optimal intensity of oral anticoagulant therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Introduction to sample size determination and power analysis for clinical trials.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000386

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-108

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-108

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-108

CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-108

The role of internal pilot studies in increasing the efficiency of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-108

Internal pilot studies I: type I error rate of the naive t-test

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21083927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluating the efficiency of targeted designs for randomized clinical trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21083927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A flexible strategy for testing subgroups and overall population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21083927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1745-6215-11-108

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference